PE anti-mouse CD206 (MMR) Antibody

Pricing & Availability
Clone
C068C2 (See other available formats)
Regulatory Status
RUO
Other Names
MMR (macrophage mannose receptor), MR (mannose receptor), MRC1
Isotype
Rat IgG2a, κ
Ave. Rating
Submit a Review
Product Citations
publications
C068C2_PE_1_082911
Thioglycollate-elicited BALB/c peritoneal macrophages were surface stained with CD107b (Mac-3) APC, and then intracellularly stained with CD206 (clone C068C2) PE (top) or rat IgG2a, κ PE isotype control (bottom).
  • C068C2_PE_1_082911
    Thioglycollate-elicited BALB/c peritoneal macrophages were surface stained with CD107b (Mac-3) APC, and then intracellularly stained with CD206 (clone C068C2) PE (top) or rat IgG2a, κ PE isotype control (bottom).
  • C068C2_PE_2_082911
See PE spectral data
Cat # Size Price Quantity Check Availability Save
141705 25 µg 84,00€
Check Availability


Need larger quantities of this item?
Request Bulk Quote
141706 100 µg 196,00€
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

CD206, also known as mannose receptor (MR), is a 175 kD type I membrane protein. It is a pattern recognition receptor (PRR) belonging to the C-type lectin superfamily. MR is expressed on macrophages, dendritic cells, Langerhans cells, and hepatic or lymphatic endothelial cells. MR recognizes a range of microbial carbohydrates bearing mannose, fucose, or N-acetyl glucosamine through its C-type lectin-like carbohydrate recognition domains, sulfated carbohydrate antigens through its cysteine-rich domain, and collagens through its fibronectin type II domain. MR mediates endocytosis and phagocytosis as well as activation of macrophages and antigen presentation. It plays an important role in host defense and provides a link between innate and adaptive immunity. Recently, MR on lymphatic endothelial cells was found to be involved in leukocyte trafficking and a contributor to the metastatic behavior of cancer cells. It suggests that MR may be a potential target in controlling inflammation and cancer metastasis by targeting the lymphatic vasculature.

Product Details
Technical Data Sheet (pdf)

Product Details

Reactivity
Mouse
Antibody Type
Monoclonal
Host Species
Rat
Immunogen
Recombinant mouse CD206 (MMR)
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The antibody was purified by affinity chromatography and conjugated with PE under optimal conditions.
Concentration
0.2 mg/ml
Storage & Handling
The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application

ICFC - Quality tested
FC - Verified

Recommended Usage

Each lot of this antibody is quality control tested by intracellular immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤0.5 µg per million cells in 100 µl volume.  It is recommended that the reagent be titrated for optimal performance for each application.

Excitation Laser
Blue Laser (488 nm)
Green Laser (532 nm)/Yellow-Green Laser (561 nm)
Application Notes

Clone C068C2 recognizes a region similar to clone MR5D3, based on the ability of the clones to block each other.

Application References
  1. Keller J, et al. 2012. Biochem Biophys Res Commun. 417:217. PubMed
  2. Ito H, et al. 2012. J Am Soc Nephrol. 23:1797. PubMed
  3. Yang X, et al. 2015. PNAS. 112:2900. PubMed
Product Citations
  1. Ukah T, et al. 2017. J Immunol. 10.4049/jimmunol.1700410. PubMed
  2. Clarke F,et al. 2017. PLoS One. 10.1371/journal.pone.0186625. PubMed
  3. Yu Y, et al. 2018. Mol Med Rep. 17:8212. PubMed
  4. Zhang Y, et al. 2018. Sci Rep. 8:5994. PubMed
  5. Long L, et al. 2018. Bio Protoc. 8:e2815. PubMed
  6. Krukowski K, et al. 2018. Sci Rep. 8:7857. PubMed
  7. Aurélien Trompette et al. 2018. Immunity. 48(5):992-1005 . PubMed
  8. Michela Miani et al. 2018. Cell metabolism. 28(4):557-572 . PubMed
  9. Roediger B et al. 2018. Cell. 175(2):530-543 . PubMed
  10. Riopel M, et al. 2019. Mol Metab. 20:89. PubMed
  11. Feng Y, et al. 2018. J Am Soc Nephrol. 29:182. PubMed
  12. Ying W et al. 2017. Cell. 171(2):372-384 . PubMed
  13. Sadtler K, et al. 2017. Tissue Eng Part A. 23:1044. PubMed
  14. Yuan M, et al. 2017. Hum Reprod. 32:94. PubMed
  15. Chu SY, et al. 2019. Nat Commun. 10:1524. PubMed
  16. Li C, et al. 2019. JCI Insight. 5. PubMed
  17. Lee DH, et al. 2019. PLoS One. 14:e0215727. PubMed
  18. El–Achkar GA, et al. 2019. PLoS One. 14:e0216405. PubMed
  19. Li B et al. 2019. Cell reports. 26(10):2720-2737 . PubMed
  20. Morioka S, et al. 2018. Nature. 563:714. PubMed
  21. Wen HJ, et al. 2019. Cell Mol Gastroenterol Hepatol. 8:p173. PubMed
  22. Guérin MV, et al. 2019. Nat Commun. 10:4131. PubMed
  23. Mellal K, et al. 2019. Sci Rep. 9:12903. PubMed
  24. Chuan Li et al. 2017. Endocrinology. 158(9):2837-2847 . PubMed
  25. Seo JB, et al. 2019. Nat Metab. 1:86. PubMed
  26. Liu C et al. 2019. Immunity. 51(2):381-397 . PubMed
  27. An W et al. 2019. British journal of pharmacology. 176(5):699-710 . PubMed
  28. Ying W, et al. 2019. Cell Metab. 29:457. PubMed
  29. Ruiz de Azua I, et al. 2017. J Clin Invest. 127:4148. PubMed
  30. Hu S, et al. 2018. Front Immunol. 9:01. PubMed
  31. Bhattacharya A, et al. 2018. Neuropsychopharmacology. 43:2586. PubMed
  32. Sun H, et al. 2019. Mol Hum Reprod. 25:05:00. PubMed
  33. Yuan Y, et al. 2019. Clin Sci (Lond). 133:1759. PubMed
  34. Hong Y, et al. 2019. J Extracell Vesicles. 8:1670893. PubMed
  35. Giri J, et al. 2020. Cell Rep. 30:1923. PubMed
  36. Liao T, et al. 2017. Front Immunol. 8:1334. PubMed
  37. Hsu SPC, et al. 2020. J Neurooncol. 146:417. PubMed
  38. Dan H, et al. 2020. Mol Oncol. 14:795. PubMed
  39. Xiong Y, et al. 2020. J Nanobiotechnology. 18:66. PubMed
  40. Mul Fedele ML, et al. 2020. Front Cell Infect Microbiol. 10:100. PubMed
  41. Zhang J, et al. 2020. J Cell Mol Med. 24:4547. PubMed
  42. Kim JS, et al. 2020. Int J Oncol. 56:1405. PubMed
  43. Sztwiertnia I, et al. 2020. PLoS One. 15:e0233789. PubMed
  44. Lu SW, et al. 2020. Nat Commun. 3.660416667. PubMed
  45. Farini A, et al. 2020. Front Physiol. 0.738194444. PubMed
  46. Asterholm I, et al. 2012. J Lipid Res. 53: 1254. PubMed
  47. Lu X, et al. 2012. Arterioscler Thromb Vasc Biol. 32:2358. PubMed
  48. Shao H, et al. 2012. J Biol Chem. 287:35860. PubMed
  49. Stridh L, et al. 2013. J Neurosci. 33:12401. PubMed
  50. Moreno M et al. 2014. The Journal of Neuroscience. 34(24):8175-85 . PubMed
  51. Browne A, et al. 2015. Cancer Res . 75: 2811 - 2821. PubMed
  52. Deng W, et al. 2015. Clin Immunol. . PubMed
  53. Nomura M, et al. 2016. Nat Immunol. 17:216-217. PubMed
  54. Ying W, et al. 2016. Sci Rep. 6:20176. PubMed
  55. Zhou K, et al. 2016. J Cereb Blood Flow Metab. 10.1177/0271678X16648712. PubMed
  56. Suzuki T, et al. 2017. Cell Rep. 18(8):2045-2057. PubMed
  57. Leach SM, et al. 2020. Cell Rep. 33:108337. PubMed
  58. Martins L, et al. 2020. Stem Cell Res Ther. 0.786805556. PubMed
  59. Lowe PP, et al. 2020. J Neuroinflammation. 0.913888889. PubMed
  60. Tang TT, et al. 2020. Sci Adv. 6:eaaz0748. PubMed
  61. Zheng H, et al. 2021. Frontiers in Cell and Developmental Biology. 9:641527. PubMed
  62. Zheng W, et al. 2021. Wellcome Open Research. 6:52. PubMed
  63. Zheng H, et al. 2021. Frontiers in Immunology. 12:645100. PubMed
  64. Srivastava S, et al. 2020. Cancer Cell. 39(2):193-208.e10. PubMed
  65. Budhu S, et al. 2021. Cell Reports. 34(2):108620. PubMed
  66. Uzhachenko RV, et al. 2021. Cell Reports. 35(1):108944. PubMed
  67. Tacconi C, et al. 2021. Cell Reports. 35(2):108993. PubMed
  68. Dong L, et al. 2021. Cancer Cell. . PubMed
  69. Toubal A, et al. 2020. Nat Commun. 3755:11. PubMed
  70. Santopaolo M, et al. 2021. Front Immunol. 609406:12. PubMed
  71. He C, et al. 2021. Oncoimmunology. 1897295:10. PubMed
  72. Shu Y, et al. 2020. Immunology. 160:345. PubMed
  73. Al-Zaeed N, et al. 2021. Cell Death Dis. 12:611. PubMed
  74. Jia X, et al. 2021. Front Cell Dev Biol. 9:685522. PubMed
  75. Cai C, et al. 2021. Sci Rep. 11:13386. PubMed
RRID
AB_10896421 (BioLegend Cat. No. 141705)
AB_10895754 (BioLegend Cat. No. 141706)

Antigen Details

Structure
Type I transmembrane protein, 175 kD, C-type lectin superfamily
Distribution

Macrophages, dendritic cells, Langerhans cells, liver endothelial cells

Function
Pathogen recognition, endocytosis and phagocytosis, antigen presentation
Ligand/Receptor
Antigen containing mannose, fucose, or an N-acetyl glucosamine
Cell Type
Dendritic cells, Endothelial cells, Langerhans cells, Macrophages
Biology Area
Cell Biology, Immunology, Innate Immunity, Signal Transduction
Molecular Family
CD Molecules
Antigen References

1. Wileman TE, et al. 1986. P. Natl. Acad. Sci. USA 83:2501.
2. Apostolopoulos V, et al. 2001. Curr. Mol. Med. 1:469.
3. Burgdorf S, et al. 2006. J. Immunol. 176:6770.
4. McKenzie EJ, et al. 2007. J. Immunol. 178:4975.

Gene ID
17533 View all products for this Gene ID
UniProt
View information about CD206 on UniProt.org

Related FAQs

What type of PE do you use in your conjugates?
We use R-PE in our conjugates.
Why is mouse CD206 stained intracellularly and not via surface staining?

Typically, mouse CD206 surface level is relatively low under normal conditions and so intracellular staining protocol is required to get better signal.

Go To Top Version: 3    Revision Date: 04-04-2016

For research use only. Not for diagnostic use. Not for resale. BioLegend will not be held responsible for patent infringement or other violations that may occur with the use of our products.

 

*These products may be covered by one or more Limited Use Label Licenses (see the BioLegend Catalog or our website, www.biolegend.com/ordering#license). BioLegend products may not be transferred to third parties, resold, modified for resale, or used to manufacture commercial products, reverse engineer functionally similar materials, or to provide a service to third parties without written approval of BioLegend. By use of these products you accept the terms and conditions of all applicable Limited Use Label Licenses. Unless otherwise indicated, these products are for research use only and are not intended for human or animal diagnostic, therapeutic or commercial use.

 

BioLegend Inc., 8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.

ProductsHere
Insert Note Here
Save Close Clear
Lab Timer
Tools
Login / Register
Remember me
Forgot your password? Reset password?
Create an Account